On CNBC's "Halftime Report Final Trades," Bryn Talkington, managing partner at Requisite Capital Management, named AbbVie (NYSE:ABBV) as her final trade with a price target of $232.

AbbVie will participate in the Goldman Sachs 47th Annual Global Healthcare Conference, scheduled for Tuesday, June 9, 2026.

Bill Baruch, founder and president of Blue Line Futures and Blue Line Capital picked Entegris Inc (NASDAQ:ENTG). On May 27, the semiconductor chip manufacturer announced that it has entered into a non-exclusive cross-licensing agreement with JSR’s Inpria to advance EUV lithography for next-generation chip manufacturing.

Jim Lebenthal, chief market strategist and partner at Cerity Partners, believes that Oracle Corp (NYSE:ORCL) has already bottomed.

Malcolm Ethridge, managing partner at Capital Area Planning Group, expects "lots of excitement" ahead of the Worldwide Developers Conference (WWDC) for Apple Inc (NASDAQ:AAPL).

Price Action:

  • AbbVie was up 3.60%, closing at $224.94 on Thursday.
  • Entegris declined 0.32% to settle at $139.88.
  • Oracle jumped 2.61% to 4236.34 on Thursday.
  • Apple rose 0.31% to close at $311.23 on Thursday.

Photo: Shutterstock